You may qualify for one of our clinical trials! For more information about joining a clinical trial, please email research@
You Deserve the Best in Advanced Orthopedic Care
Clinical Trials for Orthopedic Pain
CURRENTLY RECRUITING
BioRestorative
This is a Phase 2 clinical trial of the investigational drug BRTX-100 (autologous hypoxic-cultured Mesenchymal Precursor Cells from bone marrow + autologous platelet lysate (APL) ) for the treatment of Lumbar Degenerative Disc Disease. BRTX-100 administered by an injection into the spinal disc. Possible benefits include the reduction of pain-related disability associated with degenerative disc disease. This study involves a total of 7 visits to our site over the course of 24 months and includes a stipend for each visit.
Learn more about Disc Degeneration >>
Learn more about this study >>
CURRENTLY RECRUITING
Mesoblast
This is a Phase 3 clinical trial of the investigational drug REXLEMESTROCEL-L combined with Hyaluronic Acid for the treatment of Lumbar Degenerative Disc Disease. REXLEMESTROCEL-L (Mesenchymal Precursor Cells) + 1% Hyaluronic Acid are administered by an injection into the spinal disc. Possible benefits include the reduction of pain-related disability associated with degenerative disc disease. This study involves a total of 7 visits to our site over the course of 24 months and includes a stipend for each follow-up visit.
Learn more about Disc Degeneration >>
Learn more about this study >>
CURRENTLY RECRUITING
STACI - iFUSE TORQ for the treatment of Sacroiliac Joint Dysfunction
This is a post-market clinical study to evaluate the effectiveness of the iFuse TORQ, a device that has been cleared by the U.S. Food and Drug Administration for SI joint fusion, to treat sacroiliac joint pain. Possible benefits include faster or more complete pain relief compared with non-surgical treatment. This study involves a total of 5 visits at our site over the course of 24 months, and includes a stipend for each visit.
Learn more about Sacroiliac Joint Fusion >>
Learn more about this study >>
CURRENTLY RECRUITING
Spine BioPharma MODEL - Clinical Trial for Degenerative Disc Disease and Low Back Pain
This is a Phase 3 clinical trial of the investigational drug SB-01 for the treatment of Lumbar Degenerative Disc Disease. SB-01 is a peptide administered by an injection into the spinal disc. Possible benefits include the reduction of pain-related disability associated with degenerative disc disease. This study involves a total of 7 visits at our site over the course of 12 months and includes a stipend for each visit.
Learn more about Disc Degeneration >>
Learn more about this study >>
